Dr. Mark Malamood Offers Commentary to Medscape on Esophagitis Research Presented at Digestive Disease Week

Mark Malamood, MD, Director of Benign Esophagology in the Temple Esophageal Disease Program, offered commentary to Medscape on research presented at Digestive Disease Week 2026 that found Tegoprazan was superior to the proton pump inhibitor (PPI) lansoprazole in rapidly healing all grades of erosive esophagitis